Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-21 Purchase |
2020-08-24 4:31 pm |
VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director |
30,000 | $0.69 | $20,700 | 53,251 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-31 Option Award |
2021-01-04 4:58 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0.4521 | 361,609 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:58 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
300,000 | $0 | 361,609 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-04 4:57 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
5,000 | $0.4521 | 160,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:57 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
150,000 | $0 | 160,000 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-04 4:55 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER |
5,000 | $0.4521 | 160,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:55 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER |
150,000 | $0 | 160,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:54 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:52 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:51 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT |
150,000 | $0 | 150,000 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-04 4:48 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER |
5,000 | $0.4521 | 237,724 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:48 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER |
150,000 | $0 | 237,724 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:47 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-01 5:35 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER |
5,000 | $0.448 | 82,724 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-01 5:33 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER |
5,000 | $0.448 | 5,000 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-01 5:28 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
5,000 | $0.448 | 5,000 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-01 5:20 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0.448 | 56,609 (Direct) |
View |